Camrelizumab

camrelizumab · Jiangsu Hengrui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

268 regulatory and trial events tracked for Camrelizumab, covering 2019-04-16 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy of Induction and Adjuvant Camrelizumab Combined With Chemoradiation for LA-HNSCC [Phase 2]